Stockreport

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504 [Yahoo! Finance]

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF EQ504 has a unique, multi-modal, non-immunosuppressive mechanism of action that is complementary to other immuno-inflammatory therapeutics EQ504 data to be presented [Read more]